Table 2.
Open in new tab

Distribution of Positive and Negative Cases in Different Subcohorts.

Cohort descriptionTrain (positive/negative)Test (positive/negative)
Gliomas vs. all other entities174/84944/213
Gliomas vs. metastatic lesions174/41144/103
Gliomas vs. meningioma174/6644/17
Gliomas vs. intracranial bleeding174/7944/20
Gliomas vs. inflammatory lesions174/29344/73
Cohort descriptionTrain (positive/negative)Test (positive/negative)
Gliomas vs. all other entities174/84944/213
Gliomas vs. metastatic lesions174/41144/103
Gliomas vs. meningioma174/6644/17
Gliomas vs. intracranial bleeding174/7944/20
Gliomas vs. inflammatory lesions174/29344/73
Table 2.
Open in new tab

Distribution of Positive and Negative Cases in Different Subcohorts.

Cohort descriptionTrain (positive/negative)Test (positive/negative)
Gliomas vs. all other entities174/84944/213
Gliomas vs. metastatic lesions174/41144/103
Gliomas vs. meningioma174/6644/17
Gliomas vs. intracranial bleeding174/7944/20
Gliomas vs. inflammatory lesions174/29344/73
Cohort descriptionTrain (positive/negative)Test (positive/negative)
Gliomas vs. all other entities174/84944/213
Gliomas vs. metastatic lesions174/41144/103
Gliomas vs. meningioma174/6644/17
Gliomas vs. intracranial bleeding174/7944/20
Gliomas vs. inflammatory lesions174/29344/73
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close